As of 12:30 PM on the 11th, Komipharm is trading at 14,250 KRW, down 1.38% from the previous day. This represents a 13.64% decline compared to August 25. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners have a net purchase of 37,617 shares of Komipharm, while institutions have a net sale of 2,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 202,973 shares, while foreigners and institutions have net sold 167,557 shares and 35,583 shares, respectively.


On September 8, Komipharm was a market issue due to the "AIFA COVID clinical trial withdrawal news causing weakness."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing